// App-Quantinova.ai

: Bromodomain inhibitors are potent epigenetic regulators of catabolic gene expression in human osteoarthritic chondrocytes

Researchers

Presenter

  • M.C. de Andrs

Principal Investigators

  • N. Madhusudan

  • C. Bountra

  • U. Oppermann

  • R.O. Oreffo

Medical Centers

  • University of Southampton Faculty of Medicine, Southampton, United Kingdom

  • University of Oxford, Structural Genomics Consortium, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • C-X-C motif chemokine ligand 8

  • Cyclooxygenase-2

  • Interleukin 1 beta

  • Matrix metalloproteinase 13

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved